Zum Inhalt springen

Press Release: Novartis Cosentyx(R) PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients

Prometheus Redaktion

-- Clinically meaningful, statistically significant efficacy achieved in primary and all secondary endpoints, including reduced steroid use; safety consistent with established Cosentyx profile1,2 -- Polymyalgia rheuma...

www.finanzen.ch

Zum Originalartikel